Shedding of NG2 by MMP-13 attenuates anoikis.

Disruption of cell-matrix interactions can lead to anoikis-apoptosis due to loss of matrix contacts. We previously showed that Nerve/glial antigen 2 (NG2) is a novel anoikis receptor. Specifically, overexpression of NG2 leads to anoikis propagation, whereas its suppression leads to anoikis attenuation. Interestingly, NG2 expression decreases in late anoikis, suggesting that NG2 reduction is also critical to this process. Thus, we hypothesized that NG2 undergoes cleavage to curtail anoikis propagation. Further, since matrix metalloproteinases (MMPs) cleave cell surface receptors, play a major role in modulating apoptosis, and are associated with death receptor cleavage during apoptosis, we further hypothesized that cleavage of NG2 could be mediated by MMPs to regulate anoikis. Indeed, anoikis conditions triggered release of the NG2 extracellular domain into condition media during late apoptosis, and this coincided with increased MMP-13 expression. Treatment with an MMP-13 inhibitor and MMP-13 siRNA increased anoikis, since these treatments blocked NG2 release. Further, NG2-positive cells exhibited increased anoikis upon MMP-13 inhibition, whereas MMP-13 inhibition did not increase anoikis in NG2-null cells, corroborating that retention of NG2 on the cell membrane is critical for sustaining anoikis, and its cleavage for mediating anoikis attenuation. Similarly, NG2 suppression with siRNA inhibited NG2 release and anoikis. In contrast, MMP-13 overexpression or exogenous MMP-13 reduced anoikis by more effectively shedding NG2. In conclusion, maintenance of NG2 on the cell surface promotes anoikis propagation, whereas its shedding by MMP-13 actions attenuates anoikis. Given that these findings are derived in the context of periodontal ligament fibroblasts, these data have implications for periodontal inflammation and periodontal disease pathogenesis.

[1]  V. Godovikova,et al.  Treponema denticola upregulates MMP-2 activation in periodontal ligament cells: interplay between epigenetics and periodontal infection. , 2014, Archives of oral biology.

[2]  J. Gamonal,et al.  Matrix metalloproteinases and myeloperoxidase in gingival crevicular fluid provide site-specific diagnostic value for chronic periodontitis. , 2014, Journal of clinical periodontology.

[3]  Ji-Yeon Kim,et al.  Tumor necrosis factor-α induces matrix metalloproteinases-3, -10, and -13 in human periodontal ligament cells. , 2014, Journal of periodontology.

[4]  M. Papich,et al.  Plasma and synovial fluid concentration of doxycycline following low-dose, low-frequency administration, and resultant inhibition of matrix metalloproteinase-13 from interleukin-stimulated equine synoviocytes. , 2014, Equine veterinary journal.

[5]  J. Willey,et al.  Rac1 is required for matrix metalloproteinase 13 production by chondrocytes in response to fibronectin fragments. , 2013, Arthritis and rheumatism.

[6]  U. Cavallaro,et al.  Multivalent proteoglycan modulation of FGF mitogenic responses in perivascular cells , 2013, Angiogenesis.

[7]  Yeoun-Hee Kim,et al.  Suppression of tunicamycin-induced CD44v6 ectodomain shedding and apoptosis is correlated with temporal expression patterns of active ADAM10, MMP-9 and MMP-13 proteins in Caki-2 renal carcinoma cells. , 2012, Oncology reports.

[8]  Kuo‐Ting Chang,et al.  Matrix metalloprotease-9 induces transforming growth factor-β(1) production in airway epithelium via activation of epidermal growth factor receptors. , 2011, Life sciences.

[9]  G. Schmid-Schönbein,et al.  Acute venous occlusion enhances matrix metalloprotease activity: Implications on endothelial dysfunction. , 2011, Microvascular research.

[10]  Min-jung Park,et al.  Murine Mesenchymal Stem Cells Suppress T Lymphocyte Activation Through IL-2 Receptor α (CD25) Cleavage by Producing Matrix Metalloproteinases , 2011, Stem Cell Reviews and Reports.

[11]  Y. Kapila,et al.  The Treponema denticola Chymotrypsin-Like Protease Dentilisin Induces Matrix Metalloproteinase-2-Dependent Fibronectin Fragmentation in Periodontal Ligament Cells , 2010, Infection and Immunity.

[12]  C. Gondi,et al.  Urokinase Plasminogen Activator Receptor and/or Matrix Metalloproteinase-9 Inhibition Induces Apoptosis Signaling through Lipid Rafts in Glioblastoma Xenograft Cells , 2010, Molecular Cancer Therapeutics.

[13]  T. Hackett,et al.  IL-13 and TH2 cytokine exposure triggers matrix metalloproteinase 7-mediated Fas ligand cleavage from bronchial epithelial cells. , 2010, The Journal of allergy and clinical immunology.

[14]  K. Wolslegel,et al.  Lymphotoxin-alphabeta heterotrimers are cleaved by metalloproteinases and contribute to synovitis in rheumatoid arthritis. , 2010, Cytokine.

[15]  Y. Kapila,et al.  Anoikis triggers Mdm2-dependent p53 degradation , 2010, Molecular and Cellular Biochemistry.

[16]  G. Schmid-Schönbein,et al.  Enhanced Matrix Metalloproteinase Activity in the Spontaneously Hypertensive Rat: VEGFR-2 Cleavage, Endothelial Apoptosis, and Capillary Rarefaction , 2010, Journal of Vascular Research.

[17]  Didier Merlin,et al.  Matrix metalloproteinase-9 functions as a tumor suppressor in colitis-associated cancer. , 2010, Cancer research.

[18]  S. Kapila,et al.  Disease-Associated Extracellular Matrix Suppresses Osteoblastic Differentiation of Human Periodontal Ligament Cells Via MMP-1 , 2010, Calcified Tissue International.

[19]  E. Lesaffre,et al.  Proteolytic roles of matrix metalloproteinase (MMP)-13 during progression of chronic periodontitis: initial evidence for MMP-13/MMP-9 activation cascade. , 2009, Journal of clinical periodontology.

[20]  Y. Kapila,et al.  TNF-α Promotes an Odontoblastic Phenotype in Dental Pulp Cells , 2009, Journal of dental research.

[21]  Ji Young Park,et al.  Porphyromonas gingivalis, Gamma Interferon, and a Proapoptotic Fibronectin Matrix Form a Synergistic Trio That Induces c-Jun N-Terminal Kinase 1-Mediated Nitric Oxide Generation and Cell Death , 2008, Infection and Immunity.

[22]  P. Lønning,et al.  The progenitor cell marker NG2/MPG promotes chemoresistance by activation of integrin-dependent PI3K/Akt signaling , 2008, Oncogene.

[23]  W. Stallcup,et al.  A role for the NG2 proteoglycan in glioma progression , 2008, Cell adhesion & migration.

[24]  P. Lastres,et al.  Characterization of progressive periodontal lesions in chronic periodontitis patients: levels of chemokines, cytokines, matrix metalloproteinase-13, periodontal pathogens and inflammatory cells. , 2008, Journal of clinical periodontology.

[25]  T. Watanabe,et al.  p27Kip1 nuclear localization and cyclin-dependent kinase inhibitory activity are regulated by glycogen synthase kinase-3 in human colon cancer cells , 2008, Cell Death and Differentiation.

[26]  J. Gamonal,et al.  MMP-13 and TIMP-1 determinations in progressive chronic periodontitis. , 2007, Journal of clinical periodontology.

[27]  T. Mustelin,et al.  Differential phosphorylation of NG2 proteoglycan by ERK and PKCα helps balance cell proliferation and migration , 2007, The Journal of cell biology.

[28]  B. Lefkove,et al.  Expression of the Neural Stem Cell Markers NG2 and L1 in Human Angiomyolipoma: Are Angiomyolipomas Neoplasms of Stem Cells? , 2007, Molecular medicine.

[29]  C. López-Otín,et al.  Matrix metalloproteinase-13 is highly expressed in destructive periodontal disease activity. , 2006, Journal of periodontology.

[30]  S. Bombardieri,et al.  Systemic sclerosis fibroblasts inhibit in vitro angiogenesis by MMP‐12‐dependent cleavage of the endothelial cell urokinase receptor , 2006, The Journal of pathology.

[31]  J. Fawcett,et al.  Two separate metalloproteinase activities are responsible for the shedding and processing of the NG2 proteoglycan in vitro , 2005, Molecular and Cellular Neuroscience.

[32]  A. Iwama,et al.  Disease-associated fibronectin matrix fragments trigger anoikis of human primary ligament cells: p53 and c-myc are suppressed , 2005, Apoptosis.

[33]  T. Mustelin,et al.  Phosphorylation of NG2 Proteoglycan by Protein Kinase C-α Regulates Polarized Membrane Distribution and Cell Motility* , 2004, Journal of Biological Chemistry.

[34]  W. Stallcup,et al.  NG2 Proteoglycan Promotes Endothelial Cell Motility and Angiogenesis via Engagement of Galectin-3 and α3β1 Integrin , 2004 .

[35]  A. Zijlstra,et al.  Collagenolysis-dependent Angiogenesis Mediated by Matrix Metalloproteinase-13 (Collagenase-3)* , 2004, Journal of Biological Chemistry.

[36]  P. Galle,et al.  Cleavage of CD95 by matrix metalloproteinase-7 induces apoptosis resistance in tumour cells , 2004, Oncogene.

[37]  Y. Kapila,et al.  Specific pro-apoptotic fibronectin fragments modulate proteinase expression in periodontal ligament cells. , 2004, Journal of periodontology.

[38]  J. Arribas,et al.  The Shedding of Betaglycan Is Regulated by Pervanadate and Mediated by Membrane Type Matrix Metalloprotease-1* , 2004, Journal of Biological Chemistry.

[39]  J. Fukushi,et al.  NG2 proteoglycan promotes endothelial cell motility and angiogenesis via engagement of galectin-3 and alpha3beta1 integrin. , 2004, Molecular biology of the cell.

[40]  G. Opdenakker,et al.  Matrix Metalloproteinase-9 Facilitates Remyelination in Part by Processing the Inhibitory NG2 Proteoglycan , 2003, The Journal of Neuroscience.

[41]  A. Samarel,et al.  Fibronectin Fragment Activation of Proline-rich Tyrosine Kinase PYK2 Mediates Integrin Signals Regulating Collagenase-3 Expression by Human Chondrocytes through a Protein Kinase C-dependent Pathway* , 2003, Journal of Biological Chemistry.

[42]  J. Eriksson,et al.  Tissue inhibitor of metalloproteinases-3 induces apoptosis in melanoma cells by stabilization of death receptors , 2003, Oncogene.

[43]  K. Nave,et al.  The Proteoglycan NG2 Is Complexed with α-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid (AMPA) Receptors by the PDZ Glutamate Receptor Interaction Protein (GRIP) in Glial Progenitor Cells , 2003, The Journal of Biological Chemistry.

[44]  G. Armitage,et al.  Specific fibronectin fragments as markers of periodontal disease status. , 2002, Journal of periodontology.

[45]  M. Weiner,et al.  Substrate Specificity of Human Collagenase 3 Assessed Using a Phage-displayed Peptide Library* , 2000, The Journal of Biological Chemistry.

[46]  E. Pasquale,et al.  The multi‐PDZ domain protein MUPP1 is a cytoplasmic ligand for the membrane‐spanning proteoglycan NG2 , 2000, Journal of cellular biochemistry.

[47]  R. Crout,et al.  Treatment with subantimicrobial dose doxycycline improves the efficacy of scaling and root planing in patients with adult periodontitis. , 2000, Journal of periodontology.

[48]  Y. Kapila,et al.  Mutations in the Heparin Binding Domain of Fibronectin in Cooperation with the V Region Induce Decreases in pp125 FAK Levels Plus Proteoglycan-mediated Apoptosis via Caspases* , 1999, The Journal of Biological Chemistry.

[49]  W. Stallcup,et al.  High-affinity Binding of Basic Fibroblast Growth Factor and Platelet-derived Growth Factor-AA to the Core Protein of the NG2 Proteoglycan* , 1999, The Journal of Biological Chemistry.

[50]  T Ochiya,et al.  PDGF (alpha)-receptor is unresponsive to PDGF-AA in aortic smooth muscle cells from the NG2 knockout mouse. , 1999, Journal of cell science.

[51]  A. Nishiyama,et al.  A central segment of the NG2 proteoglycan is critical for the ability of glioma cells to bind and migrate toward type VI collagen. , 1997, Experimental cell research.

[52]  F. Ruggiero,et al.  The Membrane-spanning Proteoglycan NG2 Binds to Collagens V and VI through the Central Nonglobular Domain of Its Core Protein* , 1997, The Journal of Biological Chemistry.

[53]  S. Kapila,et al.  Fibronectin and fibronectin fragments modulate the expression of proteinases and proteinase inhibitors in human periodontal ligament cells. , 1996, Matrix biology : journal of the International Society for Matrix Biology.

[54]  H. M. Lee,et al.  The "cyclic" regimen of low-dose doxycycline for adult periodontitis: a preliminary study. , 1996, Journal of periodontology.

[55]  A. Nishiyama,et al.  Generation of truncated forms of the NG2 proteoglycan by cell surface proteolysis. , 1995, Molecular biology of the cell.

[56]  J. Prince,et al.  The primary structure of NG2, a novel membrane-spanning proteoglycan , 1991, The Journal of cell biology.